Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer?
BJU Int
.
2011 Sep;108(5):700.
doi: 10.1111/j.1464-410X.2011.10582.x.
Authors
Emil Scosyrev
,
Edward M Messing
PMID:
21854526
DOI:
10.1111/j.1464-410X.2011.10582.x
No abstract available
Publication types
Editorial
Comment
MeSH terms
Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
Female
Humans
Male
Urinary Bladder Neoplasms / drug therapy*